Cyanotech Corporation (CYAN) financial statements (2020 and earlier)

Company profile

Business Address 73-4460 QUEEN KAAHUMANU HWY
KAILUA KONA, HI 96740
State of Incorp. NV
Fiscal Year End March 31
SIC 2833 - Medicinal Chemicals and Botanical Products (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2019
TTM
3/31/2019
3/31/2018
3/31/2017
3/31/2016
3/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1,6098401,3291,4071,2402,226
Cash and cash equivalents1,6098401,3291,4071,2402,226
Receivables1,5811,9822,6642,1352,9833,258
Inventory, net of allowances, customer advances and progress billings11,20611,2749,0347,9727,8565,678
Inventory11,20611,2749,0347,9727,8565,678
Other undisclosed current assets424496590722576632
Total current assets:14,82014,59213,61712,23612,65511,794
Noncurrent Assets
Operating lease, right-of-use asset3,909
Property, plant and equipment13,47414,75215,73416,71217,79614,754
Restricted cash and investments  65   
Other noncurrent assets234282291213696846
Other undisclosed noncurrent assets     3,521
Total noncurrent assets:17,61715,03416,09016,92518,49219,121
TOTAL ASSETS:32,43729,62629,70729,16131,14730,915
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities3,6015,9144,4194,6795,4304,980
Accounts payable2,7004,9223,5273,6664,0002,926
Accrued liabilities9019928921,0131,4301,124
Employee-related liabilities     930
Deferred revenue409
Debt3,049948655623574234
Customer advances and deposits 11911731
Contract with customer, liability626
Other undisclosed current liabilities 2,000633611 (930)
Total current liabilities:7,0599,4885,7076,0326,1214,315
Noncurrent Liabilities
Long-term debt and lease obligation, including:9,7755,3726,0236,5167,0945,109
Long-term debt, excluding current maturities6,17257103116  
Operating lease, liability3,603
Other undisclosed long-term debt and lease obligation 5,3155,9206,4007,0945,109
Liabilities, other than long-term debt57  1571048
Deferred revenue and credits  308
Deferred tax liabilities, net  15774 
Other liabilities57     
Other undisclosed noncurrent liabilities (143)(130)(151)  
Total noncurrent liabilities:9,8325,2295,8936,5227,1985,117
Total liabilities:16,89114,71711,60012,55413,3199,432
Stockholders' equity
Stockholders' equity attributable to parent15,54614,90918,10716,60717,82821,483
Common stock118117115114112111
Additional paid in capital32,81732,44732,05131,57731,58530,846
Accumulated deficit(17,389)(17,655)(14,059)(15,084)(13,869)(9,474)
Total stockholders' equity:15,54614,90918,10716,60717,82821,483
TOTAL LIABILITIES AND EQUITY:32,43729,62629,70729,16131,14730,915

Income statement (P&L) ($ in thousands)

12/31/2019
TTM
3/31/2019
3/31/2018
3/31/2017
3/31/2016
3/31/2015
Revenues29,32430,20234,11532,04231,84033,809
Revenue, net 32,04231,84033,809
Cost of revenue
(Cost of Goods and Services Sold)
(17,480)(19,736)(20,744)(19,818)(19,974)(19,343)
Gross profit:11,84410,46613,37112,22411,86614,466
Operating expenses(12,340)(13,463)(11,957)(12,906)(12,651)(14,144)
Operating income (loss):(496)(2,997)1,414(682)(785)322
Nonoperating expense  (499)(528)(282)(93)
Interest and debt expense(545)(71)(72)(67)(57)(56)
Other undisclosed income from continuing operations before equity method investments, income taxes   675756
Income (loss) from continuing operations before equity method investments, income taxes:(1,041)(3,068)843(1,210)(1,067)229
Other undisclosed income (loss) from continuing operations before income taxes(154)(511)72   
Income (loss) from continuing operations before income taxes:(1,195)(3,579)915(1,210)(1,067)229
Income tax expense (benefit)(12)(17)110(5)(3,328)(253)
Net income (loss) available to common stockholders, diluted:(1,207)(3,596)1,025(1,215)(4,395)(24)

Comprehensive Income ($ in thousands)

12/31/2019
TTM
3/31/2019
3/31/2018
3/31/2017
3/31/2016
3/31/2015
Net income (loss):(1,207)(3,596)1,025(1,215)(4,395)(24)
Comprehensive income (loss), net of tax, attributable to parent:(1,207)(3,596)1,025(1,215)(4,395)(24)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: